Rise in Prevalence of Dry Eye Disease Due to Ageing, Use of Computers to Drive Dry Eye Disease Treatment Market, Says TMR

ALBANY, N.Y., Aug. 23, 2021 /PRNewswire/ -- Anti-inflammatory products witnessed high demand in the dry eye disease treatment market accounting for nearly 42% market share in 2019, which is projected to rise to slightly over 50% by 2030. The demand for anti-inflammatory products is predicted to strengthen with clinical trials, approvals, and consistent efforts from manufacturers for novel products.

The increasing penetration of technology is playing a significant role in the growth of the dry eye disease treatment market. Product manufacturers are making efforts to gain proficiency in the intense pulsed light technology mainly for the meibomian gland dysfunction type dry eye disease.

Furthermore, manufacturers in the dry eye disease treatment market aim to obtain European regulatory clearance for use of the intense pulsed light technology. This is in a bid to expand prescription treatment for dry eye disease in the region with the first prescription drug for dry eye disease in the region launched only in 2015.

Strong expertise with attention to detail makes our market research reports stand apart, Request a Report Sample here - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77640

In the U.S., the approved therapeutics for dry eye disease is limited only to two.

The scope of the growth of the dry eye disease treatment market in the world's two regions, namely Europe and North America, with large spending power, along with the demand for the treatment of dry eyes in other parts of the world has been evaluated, which is projected to value US$ 8.7 Bn by 2030.

Dry Eye Disease Treatment Market – Key Findings of Report

Novel Contact Lenses Emerge as Effective Solution

Besides standard anti-inflammatory products and artificial tears for the treatment of the dry eye disease, contact lenses are emerging as an effective solution for the same. Researchers are collaborating with eye practitioners to create contact lenses that can replace artificial tears as a dry eye disease treatment option. The low degree of relief from artificial tears has led to the need for newer products for dry eye disease. For instance, the launch of CyteSolutions Lens by a research scholar himself at the Swanson School of Engineering who was suffering from dry eye disease for the past several years.

Request for Analysis of COVID-19 Impact on Dry Eye Disease Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77640

Such pursuits are favorable for the growth of the dry eye disease treatment market.

Adoption of Multistage Management Algorithm to Prevent Progression Gathers Steam

The multistage management algorithm is gaining acceptance for the treatment of the dry eye disease due to its evidence-based outcomes and personalized approach. Healthcare companies in the dry eye disease treatment market are investing in R&D to develop products that restore homeostasis of the ocular surface and tear film of the eyes that lead to dry eye disease.

Moreover, efforts of non-profit organizations such as The Tear Film and Ocular Surface Society to create awareness about the multistage management algorithm is favorable for the expansion of dry eye disease treatment market.

Purchase Premium Research Report on Dry Eye Disease Treatment Market - https://www.transparencymarketresearch.com/checkout.php?rep_id=77640&ltype=S

Demand for Anti-inflammatory Products Spur with Dependency on Telehealth Services

The rise in dependency on telehealth services amid COVID-19 has driven eye practitioners to prescribe safe line of treatment for dry eye disease for remote consultation. Anti-inflammatory and artificial tears products are mostly prescribed for dry eye disease via telehealth services due to their safe nature and ease of use.

The increasing consumer confidence in telehealth services for the treatment of dry eye disease is further boosting the dry eye disease treatment market.

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, ask for custom research here - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=77640

Dry Eye Disease Treatment Market – Growth Drivers

• Rise in incidence of dry eye disease, awareness, and risk of co-morbidities fuels dry eye disease treatment market
• Emergence of new line of treatment and product innovations drives the dry eye disease treatment market

Dry Eye Disease Treatment Market – Key Players

Some of the leading players in the dry eye disease treatment market are:

• Novartis AG
• Bausch Health Companies Inc.
• OASIS Medical
• Johnson & Johnson
• Allergan
• Sentiss Pharma Pvt. Ltd.
• Santen Pharmaceutical Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• RegeneRx

Global Dry Eye Disease Treatment Market: Segmentation

• Dry Eye Disease Treatment Market, by Product
• Artificial Tears
• Anti-inflammatory
• Cyclosporine
• Corticosteroid
• Others
• Punctal Plugs
• Secretagogue
• Others
• Dry Eye Disease Treatment Market, by Disease
• Evaporative Dry Eye Syndrome
• Aqueous Dry Eye Syndrome
• Dry Eye Disease Treatment Market, by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Dry Eye Disease Treatment Market, by Region
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research: 

Contact Lens Market: The global contact lens market is projected to witness considerable rise owing to rising prevalence of increased preference for contact lenses over prescribed eyeglasses for aesthetics purposes and rising cases of vision related problems like myopia.

Artificial Tears Market: The primary driver of the global artificial tears market is the growing number of cases of dry eye syndrome (DES). This syndrome is basically triggered by the forces such as prolonged exposure to digital displays, chronic conjunctivitis, poor eyelid, scars of eye injury, regular air travels, poor diet, malnutrition, the rise in the level of pollution, dry weather spells, and severe climatic changes.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]  

Website: https://www.transparencymarketresearch.com/  
Follow Us: Twitter | LinkedIn 
Blog: https://tmrblog.com/

Press Release: https://www.transparencymarketresearch.com/pressrelease/dry-eye-disease-treatment-market.htm

SOURCE Transparency Market Research